Activation and oligomerization of BAK protein / response to mycotoxin / BH domain binding / B cell negative selection / BAK complex / apoptotic process involved in blood vessel morphogenesis / negative regulation of endoplasmic reticulum calcium ion concentration / response to fungus / limb morphogenesis / apoptotic process in bone marrow cell ...Activation and oligomerization of BAK protein / response to mycotoxin / BH domain binding / B cell negative selection / BAK complex / apoptotic process involved in blood vessel morphogenesis / negative regulation of endoplasmic reticulum calcium ion concentration / response to fungus / limb morphogenesis / apoptotic process in bone marrow cell / Release of apoptotic factors from the mitochondria / post-embryonic camera-type eye morphogenesis / endocrine pancreas development / The NLRP1 inflammasome / dendritic cell apoptotic process / SARS-CoV-1-mediated effects on programmed cell death / dendritic cell proliferation / establishment or maintenance of transmembrane electrochemical gradient / positive regulation of mononuclear cell proliferation / positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway / BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members / negative regulation of dendritic cell apoptotic process / B cell apoptotic process / negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage / negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway / negative regulation of execution phase of apoptosis / endoplasmic reticulum calcium ion homeostasis / fertilization / regulation of growth / regulation of mitochondrial membrane permeability / calcium ion transport into cytosol / fibroblast apoptotic process / response to UV-C / mitochondrial fusion / Bcl-2 family protein complex / myeloid cell homeostasis / NFE2L2 regulating tumorigenic genes / apoptotic mitochondrial changes / porin activity / response to cycloheximide / STAT5 activation downstream of FLT3 ITD mutants / cellular response to alkaloid / thymocyte apoptotic process / hepatocyte apoptotic process / positive regulation of calcium ion transport into cytosol / pore complex / negative regulation of release of cytochrome c from mitochondria / negative regulation of reproductive process / negative regulation of developmental process / positive regulation of IRE1-mediated unfolded protein response / negative regulation of intrinsic apoptotic signaling pathway / positive regulation of release of cytochrome c from mitochondria / vagina development / germ cell development / BH3 domain binding / B cell homeostasis / positive regulation of proteolysis / negative regulation of anoikis / blood vessel remodeling / intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress / negative regulation of extrinsic apoptotic signaling pathway in absence of ligand / Pyroptosis / cellular response to unfolded protein / ectopic germ cell programmed cell death / negative regulation of protein localization to plasma membrane / animal organ regeneration / negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway / negative regulation of extrinsic apoptotic signaling pathway via death domain receptors / ovarian follicle development / extrinsic apoptotic signaling pathway in absence of ligand / heat shock protein binding / response to cytokine / negative regulation of autophagy / intrinsic apoptotic signaling pathway / release of cytochrome c from mitochondria / regulation of mitochondrial membrane potential / epithelial cell proliferation / regulation of cytokinesis / response to gamma radiation / establishment of localization in cell / cellular response to amino acid stimulus / apoptotic signaling pathway / positive regulation of protein-containing complex assembly / cellular response to gamma radiation / : / response to hydrogen peroxide / synaptic vesicle membrane / cellular response to mechanical stimulus / intrinsic apoptotic signaling pathway in response to DNA damage / endocytosis / male gonad development / RAS processing / cellular response to UV / protein-folding chaperone binding / channel activity / Interleukin-4 and Interleukin-13 signaling / neuron apoptotic process / spermatogenesis / nuclear membrane / defense response to virus 類似検索 - 分子機能
Apoptosis regulator, Bcl-X / Apoptosis regulator, Bcl-2/ BclX / Apoptosis regulator, Bcl-2, BH4 motif, conserved site / Apoptosis regulator, Bcl-2 family BH4 motif signature. / Apoptosis regulator, Bcl-2 protein, BH4 / Bcl-2 homology region 4 / Apoptosis regulator, Bcl-2 family BH4 motif profile. / BH4 Bcl-2 homology region 4 / Apoptosis regulator, Bcl-2, BH3 motif, conserved site / Apoptosis regulator, Bcl-2 family BH3 motif signature. ...Apoptosis regulator, Bcl-X / Apoptosis regulator, Bcl-2/ BclX / Apoptosis regulator, Bcl-2, BH4 motif, conserved site / Apoptosis regulator, Bcl-2 family BH4 motif signature. / Apoptosis regulator, Bcl-2 protein, BH4 / Bcl-2 homology region 4 / Apoptosis regulator, Bcl-2 family BH4 motif profile. / BH4 Bcl-2 homology region 4 / Apoptosis regulator, Bcl-2, BH3 motif, conserved site / Apoptosis regulator, Bcl-2 family BH3 motif signature. / Apoptosis regulator, Bcl-2, BH1 motif, conserved site / Apoptosis regulator, Bcl-2 family BH1 motif signature. / Apoptosis regulator, Bcl-2, BH2 motif, conserved site / Apoptosis regulator, Bcl-2 family BH2 motif signature. / Bcl-2 family / BCL (B-Cell lymphoma); contains BH1, BH2 regions / Bcl2-like / Bcl-2, Bcl-2 homology region 1-3 / Apoptosis regulator proteins, Bcl-2 family / BCL2-like apoptosis inhibitors family profile. / Bcl-2-like superfamily 類似検索 - ドメイン・相同性
THE AUTHOR STATES THAT THERE IS A DELETION OF RESIDUES 45-84 AND RESIDUES 210-233. RESIDUES ARE ...THE AUTHOR STATES THAT THERE IS A DELETION OF RESIDUES 45-84 AND RESIDUES 210-233. RESIDUES ARE CONTINUOUSLY NUMBERED IGNORING THE DELETION.
-
実験情報
-
実験
実験
手法: 溶液NMR
NMR実験
Conditions-ID
Experiment-ID
Solution-ID
タイプ
1
1
1
2D 1H-15N HSQC
1
2
1
2D 1H-13C HSQC
1
3
1
3D (H)CCH-TOCSY
1
4
1
3DCBCA(CO)NH
1
5
1
3DC(CO)NH
1
6
1
3D HNCO
1
7
1
3D HNCA
1
8
1
3D HN(CA)CB
1
9
1
3DH(CCO)NH
1
10
1
3D 1H-15N NOESY
1
11
1
3D 1H-13C NOESY
1
12
2
13C, 15N F1, F2 FILTERED 2D 1H-1H NOESY
1
13
3
13C, 15N F1, F2 FILTERED 2D 1H-1H NOESY
1
14
2
13C, 15N F1, F2 FILTERED 2D 1H-1H TOCSY
1
15
3
13C, 15N F1, F2 FILTERED 2D 1H-1H TOCSY
1
16
2
13C, 15N F2f 2D 1H-1H NOESY
1
17
2
15N F1, F2 FILTERED 2D 1H-1H TOCSY
1
18
1
3D 1H-15N TOCSY
-
試料調製
詳細
タイプ
Solution-ID
内容
Label
溶媒系
solution
1
1 MM [U-98% 13C U-98% 15N] BCL- XL, 1.1 MM PHOTOSWITCHABLE BAK, 5 MM SODIUM PHOSPHATE, 5 MM 2- MERCAPTOETHANOL, 90% H2O/10% D2O
sample_1
90% H2O/10% D2O
solution
2
1 MM [U-98% 13C U-98% 15N] BCL- XL, 1.1 MM PHOTOSWITCHABLE BAK, 5 MM SODIUM PHOSPHATE, 90% H2O/10% D2O
sample_2
90% H2O/10% D2O
solution
3
1 MM [U-98% 13C U-98% 15N] BCL-XL, 1.1 MM PHOTOSWITCHABLE BAK, 5 MM SODIUM PHOSPHATE, 100% D2O
sample_3
90% H2O/10% D2O
試料
濃度 (mg/ml)
構成要素
Isotopic labeling
Solution-ID
1mM
BCL-XL
[U-98% 13C; U-98% 15N]
1
1.1mM
PHOTOSWITCHABLEBAK
naturalabundance
1
5mM
SODIUMPHOSPHATE
naturalabundance
1
5mM
2-MERCAPTOETHANOL
naturalabundance
1
1mM
BCL-XL
[U-98% 13C; U-98% 15N]
2
1.1mM
PHOTOSWITCHABLEBAK
naturalabundance
2
5mM
SODIUMPHOSPHATE
naturalabundance
2
1mM
BCL-XL
[U-98% 13C; U-98% 15N]
3
1.1mM
PHOTOSWITCHABLEBAK
naturalabundance
3
5mM
SODIUMPHOSPHATE
naturalabundance
3
試料状態
イオン強度: 50 / pH: 7.3 / 圧: AMBIENT / 温度: 298 K
-
NMR測定
NMRスペクトロメーター
タイプ
製造業者
モデル
磁場強度 (MHz)
Spectrometer-ID
Varian INOVA
Varian
INOVA
600
1
Varian INOVA
Varian
INOVA
900
2
-
解析
NMR software
名称
バージョン
開発者
分類
CNS
BrungerA. T. et.al.
精密化
ARIA
2.3
Linge, O'DonoghueandNilges
構造決定
ARIA
2.3
Linge, O'DonoghueandNilges
精密化
NMRPipe
Delaglio, Grzesiek, Vuister, Zhu, PfeiferandBax
解析
精密化
手法: simulated annealing / ソフトェア番号: 1
NMR constraints
NOE constraints total: 3638 / NOE intraresidue total count: 1289 / NOE long range total count: 442 / NOE medium range total count: 658 / NOE sequential total count: 753 / Protein chi angle constraints total count: 0 / Protein other angle constraints total count: 0 / Protein phi angle constraints total count: 154 / Protein psi angle constraints total count: 154
代表構造
選択基準: closest to the average
NMRアンサンブル
コンフォーマー選択の基準: structures with the lowest energy 計算したコンフォーマーの数: 500 / 登録したコンフォーマーの数: 21